Mark Kowalski
Overview
Mark Kowalski received an average of $1M in total compensation, including $418K in salary, at ProNAi Therapeutics from 2017 to 2020. Mark Kowalski also received an average of $1M at Arbutus Biopharma Corp from 2013 to 2016.
- 2020
- 2019
- 2017
- 2016
- 2015
- 2014
- 2013
ProNAi TherapeuticsChief Medical Officer
ProNAi TherapeuticsChief Medical Officer
ProNAi TherapeuticsChief Medical Officer
Arbutus Biopharma CorpFormer Chief Medical Officer
Arbutus Biopharma CorpFormer Chief Medical Officer
Arbutus Biopharma CorpFormer Chief Medical Officer
Arbutus Biopharma CorpChief Medical Officer
Source: SEC filings on April 23, 2021, April 24, 2020, April 24, 2018, April 18, 2017, and April 7, 2016.
Related executives
We found 16 more executives who work or worked at ProNAi Therapeutics and Arbutus Biopharma Corp.
William Collier
Arbutus Biopharma Corp
Chief Executive Officer
Elizabeth Howard
Arbutus Biopharma Corp
General Counsel
Michael McElhaugh
Arbutus Biopharma Corp
Chief Executive Officer
Michael Sofia
Arbutus Biopharma Corp
Chief Scientific Officer
David Hastings
Arbutus Biopharma Corp
Chief Financial Officer
Stephen Dilly
ProNAi Therapeutics
Chief Executive Officer
Nick Glover
ProNAi Therapeutics
Chief Executive Officer
Barbara Klencke
ProNAi Therapeutics